CD155 is a putative therapeutic target in medulloblastoma.
Li S, McLendon R, Sankey E, Kornahrens R, Lyne AM, Cavalli FMG, McKay Z, Herndon JE 2nd, Remke M, Picard D, Gromeier M, Brown M, Thompson EM.
Li S, et al. Among authors: gromeier m.
Clin Transl Oncol. 2023 Mar;25(3):696-705. doi: 10.1007/s12094-022-02975-9. Epub 2022 Oct 27.
Clin Transl Oncol. 2023.
PMID: 36301489